Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Building an organ-specific carcinogenic database for SAR analyses.

John Young1, Weida Tong, Hong Fang

  • 1Division of Biometry and Risk Assessment, Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA. jyoung@nctr.fda.gov

Journal of Toxicology and Environmental Health. Part A
|September 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis.

Frontiers in pharmacology·2023
Same author

CircHIPK2 facilitates phenotypic switching of vascular smooth muscle cells in hypertension.

Journal of human hypertension·2023
Same author

Clinical Features and Skin Microbiome of Tinea Scrotum: An Observational Study of 113 Cases in China.

Mycopathologia·2023
Same author

CRISPR-Cas12a base editors confer efficient multiplexed genome editing in rice.

Plant communications·2023
Same author

Artificial intelligence and real-world data for drug and food safety - A regulatory science perspective.

Regulatory toxicology and pharmacology : RTP·2023
Same author

Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials.

Therapeutic advances in chronic disease·2023

This study developed a chemical carcinogenicity prediction model using structure-activity relationships (SAR). The model achieved 63% overall predictability for liver carcinogenicity, aiding FDA chemical reviews.

Area of Science:

  • Toxicology
  • Computational Chemistry
  • Drug Discovery

Background:

  • FDA requires rapid methods to predict chemical carcinogenicity for new drug approvals.
  • Structure-activity relationships (SAR) offer a promising approach for predictive modeling.
  • Existing databases like the Carcinogenic Potency Database (CPDB) lack structural information for SAR analysis.

Purpose of the Study:

  • To build a comprehensive chemical database integrating molecular structures with carcinogenicity data.
  • To develop a predictive model for organ-specific carcinogenicity using SAR.
  • To support the FDA's evaluation of new chemicals.

Main Methods:

  • Integrated molecular structures into the Carcinogenic Potency Database (CPDB).
  • Standardized multi-record data into single-entry chemical records, handling multiple studies and toxicity endpoints.

Related Experiment Videos

  • Removed inorganic chemicals, mixtures, organometallics, counterions, and hydrates for structural consistency.
  • Applied various analysis techniques to evaluate liver-specific carcinogenicity prediction.

    • Main Results:

    • Created a modified database of 999 chemicals suitable for SAR analysis.
    • Achieved an overall predictability of approximately 63% for liver carcinogenicity.
    • Reported a sensitivity of ~30% and a specificity of ~77% for the predictive model.

    Conclusions:

    • The developed SAR-based database and model provide a foundational tool for predicting chemical carcinogenicity.
    • The model demonstrates moderate accuracy, with potential for refinement and application in regulatory toxicology.
    • This approach can expedite the safety assessment of new chemicals by regulatory agencies.